These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 933082)

  • 21. Susceptibility of 3H-thymidine-prelabelled Leishmania donovani amastigotes and promastigotes to the cytotoxic activity of peritoneal, splenic and liver macrophages.
    Hockertz S; Emmendörffer A; Lohmann-Matthes ML
    Immunobiology; 1989 Jun; 179(2-3):202-13. PubMed ID: 2793202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis of Leishmania (Leishmania) chagasi amastigotes in hamsters infected with visceral leishmaniasis.
    Lindoso JA; Cotrim PC; Goto H
    Int J Parasitol; 2004 Jan; 34(1):1-4. PubMed ID: 14711584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of highly infective Leishmania promastigotes by cultivation on SNB-9 biphasic medium.
    Grekov I; Svobodová M; Nohýnková E; Lipoldová M
    J Microbiol Methods; 2011 Dec; 87(3):273-7. PubMed ID: 21889549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth cycle-dependent generation of complement-resistant Leishmania promastigotes.
    Franke ED; McGreevy PB; Katz SP; Sacks DL
    J Immunol; 1985 Apr; 134(4):2713-8. PubMed ID: 3973390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes.
    Sacks DL; Hieny S; Sher A
    J Immunol; 1985 Jul; 135(1):564-9. PubMed ID: 2582050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promastigote infectivity in Leishmania infantum.
    Grimm F; Brun R; Jenni L
    Parasitol Res; 1991; 77(3):185-91. PubMed ID: 2047365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of Leishmania donovani axenic amastigotes: their growth and biological characteristics.
    Debrabant A; Joshi MB; Pimenta PF; Dwyer DM
    Int J Parasitol; 2004 Feb; 34(2):205-17. PubMed ID: 15037106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A quick, simple method for purifying Leishmania mexicana amastigotes in large numbers.
    Hart DT; Vickerman K; Coombs GH
    Parasitology; 1981 Jun; 82(Pt 3):345-55. PubMed ID: 7243344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo assay of viability of amastigotes of Leishmania donovani.
    Hodgkinson VH; Herman R
    J Parasitol; 1980 Apr; 66(2):245-9. PubMed ID: 7391863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of virulence and pathogenesis of a canine strain of Leishmania leishmania infantum in hamsters and dogs.
    Binhazim AA; Chapman WL; Shin SS; Hanson WL
    Am J Vet Res; 1993 Jan; 54(1):113-21. PubMed ID: 8427454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening.
    Singh N; Gupta R; Jaiswal AK; Sundar S; Dube A
    J Antimicrob Chemother; 2009 Aug; 64(2):370-4. PubMed ID: 19525291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple method for maintaining, detecting and recovering virulent Leishmania donovani in hamsters.
    Anjili CO; Mbati PA; Mwangi RW; Githure JI; Koech DK
    Acta Trop; 1996 Feb; 60(4):263-7. PubMed ID: 8659325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interaction of Leishmania donovani promastigotes and human fibroblasts in vitro.
    Schwartzman JD; Pearson RD
    Am J Trop Med Hyg; 1985 Sep; 34(5):850-5. PubMed ID: 4037177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the sensitivity of Leishmania donovani promastigotes and amastigotes to hydrogen peroxide. I. Differences in sensitivity correlate with parasite-mediated removal of hydrogen peroxide.
    Channon JY; Blackwell JM
    Parasitology; 1985 Oct; 91 ( Pt 2)():197-206. PubMed ID: 4069751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E; Lang T; Glaichenhaus N; Antoine JC
    J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous lesions in hamsters caused by Leishmania donovani promastigotes derived from axenic amastigotes.
    Anjili CO; Mbati PA; Lugalia RM
    East Afr Med J; 1995 Jul; 72(7):476. PubMed ID: 7498035
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
    Samant M; Gupta R; Kumari S; Misra P; Khare P; Kushawaha PK; Sahasrabuddhe AA; Dube A
    J Immunol; 2009 Jul; 183(1):470-9. PubMed ID: 19542458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leishmania donovani: amastigote inhibition and mode of action of berberine.
    Ghosh AK; Bhattacharyya FK; Ghosh DK
    Exp Parasitol; 1985 Dec; 60(3):404-13. PubMed ID: 4076392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two geographic strains of Leishmania donovani by resistance of mice to superinfection.
    Holbrook TW; Palczuk NC
    Am J Trop Med Hyg; 1975 Jul; 24(4):704-6. PubMed ID: 125553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purine metabolism in Leishmania donovani amastigotes and promastigotes.
    Looker DL; Berens RL; Marr JJ
    Mol Biochem Parasitol; 1983 Sep; 9(1):15-28. PubMed ID: 6199667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.